A conformation-selective protein binder for a KRAS mutant inhibits the interaction between RAS and RAF

Biochem Biophys Res Commun. 2023 Feb 19:645:110-117. doi: 10.1016/j.bbrc.2023.01.019. Epub 2023 Jan 11.

Abstract

Small GTPases are key signaling nodes that regulate the cellular processes and subcellular events, and their abnormal activities and dysregulations are closely linked with diverse cancers. Here, we report the development of conformation-selective protein binders for a KRAS mutant. The conformation-specific protein binders were selected from a repebody scaffold composed of LRR (Leucine-rich repeat) modules through phage display and modular engineering against constitute active conformation of KRAS. Epitope of the selected binders was mapped to be located close to switch I of KRAS. The conformation-selective protein binders were shown to effectively block the interaction between active KRAS and RAS-binding domain of BRAF, suppressing the KRAS-mediated downstream signaling.

Keywords: Conformational selectivity; KRAS; Repebody.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Mutation
  • Neoplasms*
  • Protein Domains
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • Proto-Oncogene Proteins p21(ras)* / metabolism
  • Signal Transduction

Substances

  • Proto-Oncogene Proteins p21(ras)
  • Extracellular Signal-Regulated MAP Kinases
  • KRAS protein, human